{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T16:42:46Z","timestamp":1786207366478,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1245\/s10434-026-19903-8","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:23:59Z","timestamp":1781018639000},"page":"8555-8558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peritoneal Metastases in Stage II\u2013III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance"],"prefix":"10.1245","volume":"33","author":[{"given":"Kwasi Ansere","family":"Ofori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huxley","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Princy","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Turaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"346","key":"19903_CR1","doi-asserted-by":"publisher","first-page":"346ra92","DOI":"10.1126\/SCITRANSLMED.AAF6219","volume":"8","author":"J Tie","year":"2016","unstructured":"Tie J, Wang Y, Tomasetti C, et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016;8(346):346ra92. https:\/\/doi.org\/10.1126\/SCITRANSLMED.AAF6219.","journal-title":"Sci Transl Med."},{"issue":"12","key":"19903_CR2","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1001\/JAMAONCOL.2019.3616","volume":"5","author":"J Tie","year":"2019","unstructured":"Tie J, Cohen JD, Wang Y, et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer. JAMA Oncol. 2019;5(12):1710\u20137. https:\/\/doi.org\/10.1001\/JAMAONCOL.2019.3616.","journal-title":"JAMA Oncol."},{"issue":"12","key":"19903_CR3","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1038\/s41591-025-04030-w","volume":"31","author":"J Tie","year":"2025","unstructured":"Tie J, Wang Y, Loree JM, et al. Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2\/3 DYNAMIC-III trial. Nat Med. 2025;31(12):4291\u2013300. https:\/\/doi.org\/10.1038\/s41591-025-04030-w.","journal-title":"Nat Med."},{"issue":"11","key":"19903_CR4","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1038\/s41591-024-03254-6","volume":"30","author":"Y Nakamura","year":"2024","unstructured":"Nakamura Y, Watanabe J, Akazawa N, et al. ctDNA-based molecular residual disease and survival in resectable colorectal cancer. Nat Med. 2024;30(11):3272\u201383. https:\/\/doi.org\/10.1038\/s41591-024-03254-6.","journal-title":"Nat Med."},{"issue":"12","key":"19903_CR5","doi-asserted-by":"publisher","first-page":"e2452661","DOI":"10.1001\/JAMANETWORKOPEN.2024.52661","volume":"7","author":"J Ji","year":"2024","unstructured":"Ji J, Wang C, Goel A, et al. Circulating tumor DNA testing in curatively resected colorectal cancer and salvage resection. JAMA Netw Open. 2024;7(12):e2452661\u2013e2452661. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2024.52661.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"19903_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","volume":"9","author":"A Bartolomucci","year":"2025","unstructured":"Bartolomucci A, Nobrega M, Ferrier T, et al. Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology. NPJ Precision Oncol. 2025;9(1):84. https:\/\/doi.org\/10.1038\/s41698-025-00876-y.","journal-title":"NPJ Precision Oncol."},{"issue":"1","key":"19903_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/S12029-023-00959-8\/TABLES\/1","volume":"55","author":"JM Baumgartner","year":"2024","unstructured":"Baumgartner JM, Botta GP. Role of circulating tumor DNA among patients with colorectal peritoneal metastases. J Gastrointest Cancer. 2024;55(1):41\u20136. https:\/\/doi.org\/10.1007\/S12029-023-00959-8\/TABLES\/1.","journal-title":"J Gastrointest Cancer."},{"issue":"9","key":"19903_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/CANCERS17091461","volume":"17","author":"V Martelli","year":"2025","unstructured":"Martelli V, Vidal J, Salvans S, et al. Liquid biopsy in peritoneal carcinomatosis from colorectal cancer: current evidence and future perspectives. Cancers. 2025;17(9):1461. https:\/\/doi.org\/10.3390\/CANCERS17091461.","journal-title":"Cancers."},{"issue":"3","key":"19903_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/CJP2.207","volume":"7","author":"I van\u2019t Erve","year":"2021","unstructured":"van\u2019t Erve I, Rovers KP, Constantinides A, et al. Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid. J Pathol Clin Res. 2021;7(3):203\u20138. https:\/\/doi.org\/10.1002\/CJP2.207.","journal-title":"J Pathol Clin Res."},{"issue":"1","key":"19903_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1245\/S10434-022-12399-Y","volume":"30","author":"BG Sullivan","year":"2022","unstructured":"Sullivan BG, Lo A, Yu J, et al. Circulating tumor DNA is unreliable to detect somatic gene alterations in gastrointestinal peritoneal carcinomatosis. Ann Surg Oncol. 2022;30(1):278. https:\/\/doi.org\/10.1245\/S10434-022-12399-Y.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"19903_CR11","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-020-1063-5","volume":"26","author":"Y Nakamura","year":"2020","unstructured":"Nakamura Y, Taniguchi H, Ikeda M, et al. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies. Nat Med. 2020;26(12):1859\u201364. https:\/\/doi.org\/10.1038\/s41591-020-1063-5.","journal-title":"Nat Med."},{"issue":"3","key":"19903_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/ANNONC\/MDT591","volume":"25","author":"N Hugen","year":"2014","unstructured":"Hugen N, Van de Velde CJH, De Wilt JHW, Nagtegaal ID. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014;25(3):651. https:\/\/doi.org\/10.1093\/ANNONC\/MDT591.","journal-title":"Ann Oncol."},{"issue":"1","key":"19903_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1102\/1470-7330.2011.0016","volume":"11","author":"CM Patel","year":"2011","unstructured":"Patel CM, Sahdev A, Reznek RH. CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging. 2011;11(1):123. https:\/\/doi.org\/10.1102\/1470-7330.2011.0016.","journal-title":"Cancer Imaging."},{"issue":"1","key":"19903_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3348\/KJR.2023.0840","volume":"25","author":"C Fu","year":"2024","unstructured":"Fu C, Zhang B, Guo T, Li J. Imaging evaluation of peritoneal metastasis: current and promising techniques. Korean J Radiol. 2024;25(1):86. https:\/\/doi.org\/10.3348\/KJR.2023.0840.","journal-title":"Korean J Radiol."},{"key":"19903_CR15","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00535","author":"H Bando","year":"2022","unstructured":"Bando H, Nakamura Y, Taniguchi H, et al. Effects of metastatic sites on circulating tumor DNA in patients with metastatic colorectal cancer. JCO Precis Oncol. 2022. https:\/\/doi.org\/10.1200\/PO.21.00535.","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"19903_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/XCS.0000000000001028","volume":"238","author":"VV Bansal","year":"2024","unstructured":"Bansal VV, Belmont E, Godley F, et al. Utility of circulating tumor DNA assessment in characterizing recurrence sites after optimal resection for metastatic colorectal cancer. J Am Coll Surg. 2024;238(6):1013\u201320. https:\/\/doi.org\/10.1097\/XCS.0000000000001028.","journal-title":"J Am Coll Surg."},{"issue":"10","key":"19903_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","volume":"4","author":"CEL Klaver","year":"2019","unstructured":"Klaver CEL, Wisselink DD, Punt CJA, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol. 2019;4(10):761\u201370. https:\/\/doi.org\/10.1016\/S2468-1253(19)30239-0.","journal-title":"Lancet Gastroenterol Hepatol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19903-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19903-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19903-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:49:03Z","timestamp":1786204143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19903-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["19903"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19903-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kiran Turaga is an advisory board member for Astra Zeneca.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Ethics"}}]}}